Rigel Pharma (RIGL) Tops Q2 EPS by 12c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $35.61 -0.34%
Financial Fact:
Contract revenues from collaborations: 3.76M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Financial Fact:
Contract revenues from collaborations: 3.76M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q2 EPS of $0.04, $0.12 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $26.89 million versus the consensus estimate of $25.7 million.
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
- Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
